KRTAP4-9, a keratin-associated protein found in humans, is intricately involved in processes related to aging and the regulation of the hair cycle. The predicted cytosolic localization of KRTAP4-9 indicates its active participation in intracellular events, suggesting a pivotal role in the cellular mechanisms associated with these biological phenomena. As an integral component influencing the dynamics of aging and the hair cycle, KRTAP4-9 likely functions within intricate signaling networks, contributing to the coordination of cellular processes that govern these physiological processes.
Inhibition of KRTAP4-9 involves the strategic modulation of various cellular pathways that regulate aging and hair cycle dynamics. The identified inhibitors target specific cellular signaling pathways associated with KRTAP4-9, influencing its activity indirectly or directly. For instance, inhibitors targeting the mTOR signaling pathway, such as Rapamycin, disrupt cellular processes involved in aging, potentially impacting KRTAP4-9 function. The SIRT1 activator Resveratrol modulates pathways related to aging, offering an avenue for indirect regulation of KRTAP4-9. Similarly, inhibitors of TGF-β receptor, MEK, PI3K/AKT, JNK, and p38 MAPK pathways affect cellular processes associated with hair cycle regulation, influencing KRTAP4-9 function. Additionally, modulators targeting histone modifications (LSD1 inhibitor), ALK pathway (ALK inhibitor), and Rac1 signaling (Rac1 inhibitor) provide further insights into the potential regulatory mechanisms governing KRTAP4-9. These inhibitors collectively present a comprehensive approach to understanding and potentially manipulating the function of KRTAP4-9 within the intricate cellular networks governing aging and hair cycle dynamics. In summary, KRTAP4-9 emerges as a critical player in the orchestration of aging and hair cycle regulation, with its inhibition intricately linked to the modulation of specific cellular pathways. The identified inhibitors, each targeting distinct signaling cascades, offer valuable tools for researchers to explore the nuanced regulatory mechanisms associated with KRTAP4-9. This knowledge not only enhances our understanding of the functional aspects of KRTAP4-9 but also opens avenues for future investigations into the broader cellular processes governing aging and hair cycle dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor disrupting the mTOR signaling pathway, potentially influencing KRTAP4-9 by regulating cellular processes related to aging and hair cycle. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator influencing the SIRT1 pathway, potentially modulating KRTAP4-9 through pathways associated with aging and cellular processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor affecting the TGF-β signaling pathway, potentially impacting KRTAP4-9 by regulating pathways related to hair cycle and cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor affecting the MAPK pathway, potentially influencing KRTAP4-9 through pathways associated with cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor disrupting the PI3K/AKT pathway, potentially modulating KRTAP4-9 through pathways associated with aging and cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK pathway, potentially influencing KRTAP4-9 through pathways associated with cellular processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor affecting the MAPK pathway, potentially impacting KRTAP4-9 through pathways associated with cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor disrupting the PI3K/AKT pathway, potentially modulating KRTAP4-9 through pathways associated with aging and cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor affecting the p38 MAPK pathway, potentially influencing KRTAP4-9 through pathways associated with cellular processes. | ||||||
TAE684 | 761439-42-3 | sc-364626 sc-364626A | 5 mg 50 mg | $188.00 $988.00 | 2 | |
ALK inhibitor affecting the ALK pathway, potentially influencing KRTAP4-9 through pathways associated with cellular processes. | ||||||